Exact Sciences (EXAS) Stock Trades Up, Here Is Why [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
quarter 2025 results which beat analysts' revenue and EBITDA expectations and included full-year revenue guidance that slightly exceeded Wall Street's estimates. Sales grew 11% from the previous year, driven by a 14% rise in screening revenue, while precision oncology grew more modestly at 4% on a core basis. The sales bump largely came from the expansion of the company's test menu and stronger execution in its commercial teams. Overall, this print had some key positives. Is now the time to buy Exact Sciences? Access our full analysis report here, it's free Exact Sciences's shares are very volatile and have had 23 moves greater than 5% over the last year. But moves this big are rare even for Exact Sciences and indicate this news significantly impacted the market's perception of the business. The biggest move we wrote about over the last year was 2 months ago when the stock dropped 5.9% on the news that the company reported underwhelming fourth-quarter results as profit margins w
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? [Yahoo! Finance]Yahoo! Finance
- November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]Seeking Alpha
- Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]Yahoo! Finance
- Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCSBusiness Wire
- Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]Seeking Alpha
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 12/5/25 - Form SCHEDULE
- 11/26/25 - Form DEFA14A
- 11/24/25 - Form DEFA14A
- EXAS's page on the SEC website